Immune Checkpoint Inhibitors in Uro-Oncology: Urgent Call for Biomarkers.

Published in: Cancers (2020)

Bladder cancer and renal cell carcinoma (RCC) are the second and third most commonly diagnosed cancers in the field of uro-oncology [...].

Keyphrases